Eyenovia, Inc. announced on February 5, 2025, significant progress in the development of its novel, user-filled Optejet dispenser. The company anticipates filing for U.S. regulatory approval for this device in the fourth quarter of 2025.
The user-filled Optejet is designed to address common difficulties with traditional eye drops, such as inaccurate administration and discomfort. It features a sterile disposable cartridge that users can fill with their own ophthalmic liquids, capable of dispensing up to 180 metered sprays.
Rigorous testing has shown the Optejet's durable base unit performing over 30,000 sprays, with 98% of sprays consistently between 8-9 microliters. This device is designed for versatile applications, including artificial tears and lens rewetting products, targeting multi-billion dollar ophthalmic markets, such as the $4 billion U.S. market for artificial tears and lens rewetting products.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.